JP2009534449A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009534449A5 JP2009534449A5 JP2009507113A JP2009507113A JP2009534449A5 JP 2009534449 A5 JP2009534449 A5 JP 2009534449A5 JP 2009507113 A JP2009507113 A JP 2009507113A JP 2009507113 A JP2009507113 A JP 2009507113A JP 2009534449 A5 JP2009534449 A5 JP 2009534449A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- group
- formula
- amino acid
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000000539 amino acid group Chemical group 0.000 claims 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000003636 chemical group Chemical group 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000032383 Soft tissue cancer Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- -1 hydroxyl compound Chemical class 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010023825 Laryngeal cancer Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010027406 Mesothelioma Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 claims 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 208000012868 Overgrowth Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 206010023841 laryngeal neoplasm Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 230000001394 metastastic effect Effects 0.000 claims 1
- 206010061289 metastatic neoplasm Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000006958 oropharynx cancer Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000861 pro-apoptotic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
- 0 CC(C(C(c1ccccc11)=O)=C(*)C1=O)N* Chemical compound CC(C(C(c1ccccc11)=O)=C(*)C1=O)N* 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0651461A FR2900150B1 (fr) | 2006-04-25 | 2006-04-25 | Composes de type 1,4-naphtoquinones, compositions les comprenant et utilisation de ces composes en tant qu'agent anti-cancereux |
| PCT/FR2007/000703 WO2007125196A1 (fr) | 2006-04-25 | 2007-04-25 | Composés de type 1, 4-naphtoquinones, compositions les comprenant et utilisation de ces composés en tant qu'agents anti -cancéreux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009534449A JP2009534449A (ja) | 2009-09-24 |
| JP2009534449A5 true JP2009534449A5 (enExample) | 2010-06-17 |
Family
ID=37681680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507113A Withdrawn JP2009534449A (ja) | 2006-04-25 | 2007-04-25 | １，４−ナフトキノン系化合物、該化合物を含んでなる組成物、およびこれらの化合物の抗がん剤としての使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090247472A1 (enExample) |
| EP (1) | EP2010481A1 (enExample) |
| JP (1) | JP2009534449A (enExample) |
| AU (1) | AU2007245621A1 (enExample) |
| CA (1) | CA2650480A1 (enExample) |
| FR (1) | FR2900150B1 (enExample) |
| WO (1) | WO2007125196A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2093207A1 (en) * | 2008-02-06 | 2009-08-26 | Julius-Maximilians-Universität Würzburg | Antiinfective and antitumoral compounds isolated from tropical lianas |
| AU2013232208B2 (en) * | 2012-03-14 | 2017-04-27 | Indiana University Research And Technology Corporation | Compounds and methods for treating leukemia |
| US10011549B2 (en) * | 2015-07-06 | 2018-07-03 | Robert Bosch Gmbh | Electrochemically active agents for pH modulation in biological buffers |
| TWI738334B (zh) * | 2019-10-22 | 2021-09-01 | 國立清華大學 | 萘醌衍生物用於抑制癌細胞的增殖及轉移的用途 |
| WO2024085824A1 (en) * | 2022-10-19 | 2024-04-25 | İsti̇nye Üni̇versi̇tesi̇ | An antimetastatic agent effective on prostate cancer cells and suitable for use in the treatment of these diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55111499A (en) * | 1979-02-21 | 1980-08-28 | Takeda Chem Ind Ltd | Glucosamine derivative and its preparation |
-
2006
- 2006-04-25 FR FR0651461A patent/FR2900150B1/fr not_active Expired - Fee Related
-
2007
- 2007-04-25 WO PCT/FR2007/000703 patent/WO2007125196A1/fr not_active Ceased
- 2007-04-25 EP EP07731362A patent/EP2010481A1/fr not_active Withdrawn
- 2007-04-25 JP JP2009507113A patent/JP2009534449A/ja not_active Withdrawn
- 2007-04-25 AU AU2007245621A patent/AU2007245621A1/en not_active Abandoned
- 2007-04-25 CA CA002650480A patent/CA2650480A1/fr not_active Abandoned
- 2007-04-25 US US12/298,307 patent/US20090247472A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019512478A5 (enExample) | ||
| JP2014528467A5 (enExample) | ||
| JP2020517616A5 (enExample) | ||
| JP2011522789A5 (enExample) | ||
| JP2017536344A5 (enExample) | ||
| JP2008540554A5 (enExample) | ||
| JP2009530392A5 (enExample) | ||
| JP2016505586A5 (enExample) | ||
| JP2008528671A5 (enExample) | ||
| JP2008535902A5 (enExample) | ||
| RU2016126503A (ru) | Аналоги кортистатина, их синтез и применения | |
| JP2010511721A5 (enExample) | ||
| JP2016153410A5 (enExample) | ||
| JP2018504378A5 (enExample) | ||
| JP2017528467A5 (enExample) | ||
| JP2018504379A5 (enExample) | ||
| JP2007501793A5 (enExample) | ||
| JP2019529518A5 (enExample) | ||
| JP2009536221A5 (enExample) | ||
| JP2020506951A5 (enExample) | ||
| CA2750413A1 (en) | Hydroxamic acid derivatives | |
| CA2653941A1 (en) | Substituted amino purine derivatives and uses thereof | |
| JP2011513410A5 (enExample) | ||
| JP2017509586A5 (enExample) | ||
| JP2015512943A5 (enExample) |